Illumina ‘Pushes Back’ on European Commission’s ‘PushBack’ of Grail Acquisition Gajus - stock.adobe.com

llumina has filed an action to annul the European Commission’s decision to have the Grail acquisition reviewed. About a week ago, the European Commission Directorate-General called for antitrust regulators to examine San Diego, CA-based Illumina’s  $8.1 billion acquisition of the liquid biopsy specialist.